2021
DOI: 10.1016/j.nefro.2020.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 2 publications
1
1
0
Order By: Relevance
“…High ESR has been reported as an independent predictive factor for renal AA amyloidosis 8 . In the present study, we highlight a case previously reported by Domingos et al 4 . The patient presented with nephrotic syndrome and ERS >100 mm/h at the time of kidney biopsy and was successfully treated with etanercept.…”
Section: Discussionsupporting
confidence: 77%
See 1 more Smart Citation
“…High ESR has been reported as an independent predictive factor for renal AA amyloidosis 8 . In the present study, we highlight a case previously reported by Domingos et al 4 . The patient presented with nephrotic syndrome and ERS >100 mm/h at the time of kidney biopsy and was successfully treated with etanercept.…”
Section: Discussionsupporting
confidence: 77%
“…Recently, Domingos et al 4 reported the case of a 78-year-old woman with a seronegative polyarthritis evolving for 10 years and corticoid-induced diabetes mellitus who presented to the nephrology department for NS (anasarca, sCr of 1.3 mg/dL, 10.4 g/24h of proteinuria, and hypoalbuminemia of 1.4 g/dL). She also complained of constitutional symptoms, diarrhea, and inflammatory arthralgia.…”
Section: Resultsmentioning
confidence: 99%